MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
0.3980
+0.0180
+4.74%
After Hours: 0.4079 +0.0099 +2.49% 19:59 12/08 EST
OPEN
0.3950
PREV CLOSE
0.3800
HIGH
0.4209
LOW
0.3825
VOLUME
2.27M
TURNOVER
0
52 WEEK HIGH
9.81
52 WEEK LOW
0.3724
MARKET CAP
9.49M
P/E (TTM)
-0.0355
1D
5D
1M
3M
1Y
5Y
Tonix Pharmaceut: Current report
Press release · 9h ago
Reported Earlier, "WHO 'Very Worried' About Spread Of Mpox In DRC" - Reuters News
A severe form of mpox has killed nearly 600 people in the democratic republic of congo this year. The world health organization is "very worried" about the spread of clade i mpox, a more virulent form of the virus. The disease has been reported in 13,000 cases in 2023, twice as many as in 2020.
Benzinga · 14h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers exicure stock rose 54.5% to $0.66 during thursday's after-market session. Aligos therapeutics stock moved upwards by 33.84% and tonix pharmaceuticals stock rose 7.86%. Processa pharma stock decreased by 9.53% and 89bio stock fell 7.04%.
Benzinga · 1d ago
Tonix Pharmaceut: Current report
Press release · 4d ago
FDA Clears Phase 2 Study Of TNX-2900 In Prader-Willi Syndrome
NASDAQ · 4d ago
Tonix stock climbs as PWS therapy cleared for clinical studies
Tonix stock climbs as pws therapy cleared for clinical studies. Fda cleared the drugmaker's application to support clinical development of tnx-2900 for the treatment of prader-willi syndrome. Shares of tonix pharmaceuticals rose 11% premarket on monday.
Seeking Alpha · 4d ago
Weekly Report: what happened at TNXP last week (1127-1201)?
Weekly Report · 4d ago
Weekly Report: what happened at TNXP last week (1120-1124)?
Weekly Report · 11/27 11:39
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg. Its portfolio consists of central nervous system (CNS), rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases and cancer. Its infectious disease portfolio includes a vaccine in development to prevent smallpox and mpox, vaccines to prevent COVID-19, a platform to make fully human monoclonal antibodies (mAbs), to treat COVID-19 and humanized anti-SARS-CoV-2 mAbs. Its product candidates include TNX-102 SL, TNX-4300, TNX-1900, TNX-601 ER and others.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.